These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32571814)

  • 1. Effectiveness of Vancomycin Dosing Guided by Therapeutic Drug Monitoring in Adult Patients Receiving Extracorporeal Membrane Oxygenation.
    Marella P; Roberts J; Hay K; Shekar K
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Diehl A; Gilder E; Jakob SM; Kim HS; Levkovich BJ; Lim SY; McGuinness S; Parke R; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Fraser JF; Shekar K; Roberts JA;
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0137721. PubMed ID: 34633852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software.
    Roberts JA; Bellomo R; Cotta MO; Koch BCP; Lyster H; Ostermann M; Roger C; Shekar K; Watt K; Abdul-Aziz MH
    Intensive Care Med; 2022 Oct; 48(10):1338-1351. PubMed ID: 35997793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Vancomycin Dosage and Plasma Levels in Critically Ill Adult Patients Requiring Extracorporeal Membrane Oxygenation (ECMO).
    Ferre A; Giglio A; Zylbersztajn B; Valenzuela R; Van Sint Jan N; Fajardo C; Reccius A; Dreyse J; Hasbun P
    J Intensive Care Med; 2024 Sep; 39(9):909-915. PubMed ID: 38557265
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic Assessment of Pre- and Post-Oxygenator Vancomycin Concentrations in Extracorporeal Membrane Oxygenation: A Prospective Observational Study.
    Mahmoud AA; Avedissian SN; Al-Qamari A; Bohling T; Pham M; Scheetz MH
    Clin Pharmacokinet; 2020 Dec; 59(12):1575-1587. PubMed ID: 32468446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury is a frequent complication in critically ill neonates receiving extracorporeal membrane oxygenation: a 14-year cohort study.
    Zwiers AJ; de Wildt SN; Hop WC; Dorresteijn EM; Gischler SJ; Tibboel D; Cransberg K
    Crit Care; 2013 Jul; 17(4):R151. PubMed ID: 23883698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes among Patients Treated with Renal Replacement Therapy during Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Study.
    Dado DN; Ainsworth CR; Thomas SB; Huang B; Piper LC; Sams VG; Batchinsky A; Morrow BD; Basel AP; Walter RJ; Mason PE; Chung KK
    Blood Purif; 2020; 49(3):341-347. PubMed ID: 31865351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation.
    Askenazi DJ; Selewski DT; Paden ML; Cooper DS; Bridges BC; Zappitelli M; Fleming GM
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1328-36. PubMed ID: 22498496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Extracorporeal Membrane Oxygenation on the New Vancomycin Dosing Regimen in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration.
    Yang CJ; Wu CW; Wu CC
    Ther Drug Monit; 2018 Jun; 40(3):310-314. PubMed ID: 29746432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation.
    Wu CC; Shen LJ; Hsu LF; Ko WJ; Wu FL
    J Formos Med Assoc; 2016 Jul; 115(7):560-70. PubMed ID: 26123638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
    Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS
    Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Drug Monitoring of Vancomycin in Pediatric Patients With Extracorporeal Membrane Oxygenation Support.
    Zylbersztajn BL; Izquierdo G; Santana RC; Fajardo C; Torres JP; Cordero J; Valverde C
    J Pediatr Pharmacol Ther; 2018; 23(4):305-310. PubMed ID: 30181721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
    Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: an ASAP ECMO Study.
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Diehl A; Gilder E; Jakob SM; Kim HS; Levkovich BJ; Lim SY; McGuinness S; Parke R; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Fraser JF; Shekar K; Roberts JA;
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0143821. PubMed ID: 34460303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Individualized vancomycin dosing for a patient diagnosed as severe acute pancreatitis with concurrent extracorporeal membrane oxygenation and continuous veno-venous hemofiltration therapy: a case report].
    He N; Yan YY; Ying YQ; Yi M; Yao GQ; Ge QG; Zhai SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):915-920. PubMed ID: 30337758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Renal Failure and Renal Replacement Therapy on Outcome During Extracorporeal Membrane Oxygenation Therapy.
    Antonucci E; Lamanna I; Fagnoul D; Vincent JL; De Backer D; Silvio Taccone F
    Artif Organs; 2016 Aug; 40(8):746-54. PubMed ID: 27139839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic dosing during extracorporeal membrane oxygenation: does the system matter?
    Abdul-Aziz MH; Roberts JA
    Curr Opin Anaesthesiol; 2020 Feb; 33(1):71-82. PubMed ID: 31764007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcome of acute kidney injury by the pRIFLE criteria for children receiving extracorporeal membrane oxygenation after heart surgery.
    Elella RA; Habib E; Mokrusova P; Joseph P; Aldalaty H; Ahmadi MA; Halees ZA
    Ann Saudi Med; 2017; 37(3):201-206. PubMed ID: 28578358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Hemolysis on Acute Kidney Injury and Mortality in Children Supported with Cardiac Extracorporeal Membrane Oxygenation.
    Borasino S; Kalra Y; Elam AR; Carlisle O'Meara L; Timpa JG; Goldberg KG; Collins Gaddis JL; Alten JA
    J Extra Corpor Technol; 2018 Dec; 50(4):217-224. PubMed ID: 30581228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.